Adipose tissue hypoxia and endoplasmic reticulum (ER) stress may link the presence of chronic inflammation and macrophage infiltration in severely obese subjects. We previously reported the up-regulation of TNF-like weak inducer of apoptosis (TWEAK)/ fibroblast growth factorinducible 14 (Fn14) axis in adipose tissue of severely obese type 2 diabetic subjects.
glycemia, hyperlipidemia, hypertension, and asthma (1) . Recently cellular inflammation has emerged as an important mediator of these dysfunctions (2) .
Tissue inflammation appears as a response to oxidative stress (3), endoplasmic reticulum (ER) stress (4) , and local hypoxia (2) . In obesity, hypoxia appears in clusters of adipocytes that become distant from the vasculature as adipose tissue expands (2) . These hypoxic patches/clusters of adipocytes enhance ER stress and produce reactive oxygen species, which worsen the inflammatory pathways. These hypoxia-induced processes are highly integrated and work in vicious circles as the tissue tries to overcome the chronic metabolic imbalance. Recently a multifunctional cytokine named TNF-like weak inducer of apoptosis (TWEAK) that controls many cellular activities has emerged as a new player in the inflammatory processes (5) . TWEAK actions are mediated by its binding to fibroblast growth factor-inducible 14 (Fn14), a highly inducible cell surface receptor that has been linked to several intracellular signaling pathways, including the nuclear factor-B (NF-B) pathway (6) . Activation of the proinflammatory transcription factor NF-B in monocytes and adipocytes is a consistent finding in obese patients (7) . The activation of NF-B can lead to the release of proinflammatory mediators that may also interfere with insulin signaling, causing insulin resistance. It is presently unknown whether TWEAK might play a role in the pathological proinflammatory and hypoxic process associated with obesity. Recently preponderant roles of TWEAK and Fn14 in brain ischemic injuries in human patients have been reported (8) . In cerebral ischemia, there is a marked up-regulation of both TWEAK and the receptor Fn14. Interference with TWEAK signaling reduced the infarct size 2 d after the onset of ischemia (9) .
We previously reported an increase of TWEAK and Fn14 gene expression in sc adipose tissue (SAT) of severely obese type 2 diabetic patients (10) . Likewise, severely obese subjects are characterized by elevated adiposity that can generate hypoxic patches and a high degree of systemic inflammation (11, 12) . In this study, to explore further the role of TWEAK and Fn14 in human obesity within the context of hypoxia, inflammation, and ER stress, we examined TWEAK and Fn14 expression levels in cohorts of obese, type 2 diabetes, and severely obese patients in SAT and visceral adipose tissue (VAT) biopsies from the same subject in relation to several hypoxia and ER stress surrogate genes. The effect of hypoxia, inflammation, and ER stress on the expression of TWEAK and Fn14 was also examined in human adipocyte and macrophage cell lines. 
Patients and Methods

Selection of patients
A total of 96 Caucasian subjects were recruited at the University Hospital Joan XXIII (Tarragona, Spain) and the Hospital Virgen de la Victoria (Malaga, Spain). All were of white origin and reported that their body weight had been stable for at least 3 months before the study. They had no systemic disease other than obesity or type 2 diabetes, and all had been were free of any infections during the month before the study. Liver and renal diseases were specifically excluded by biochemical work-up. VAT and SAT biopsies were obtained from all 96 subjects. Samples were obtained during abdominal elective surgical procedures (cholecystectomy, surgery for abdominal hernia or during bariatric surgery). The hospitals' ethics committees approved the study, and informed consent was obtained from all participants. For the obesity study, a cohort of 19 lean, 28 overweight, and 15 obese nondiabetic subjects were selected. For the severe obesity study, a cohort of 23 severely obese subjects was included in the study. For intergroup gene expression comparisons, we selected an age-and gender-matched population of 35 overweight subjects as a control group. None of the morbidly obese subjects were receiving insulin therapy or oral antidiabetic or antilipemic agents. For the type 2 diabetes study, patients were classified as having type 2 diabetes mellitus according to the American Diabetes Association criteria. According to these criteria, we selected 11 type 2 diabetic obese subjects and 36 nondiabetic obese subjects for the intergroup comparison. Pharmacological treatment of the patients with type 2 diabetes mellitus was: insulin, 9.1%; oral hypoglycemic agents, 54.5%; diet, 9.1%; statins, 63.6%; fibrates, 0%; blood pressure-lowering agents, 54.5%.
Collection and processing of biological samples
All patients had fasted at least 12 h before the surgical procedure. SAT was collected at the site of surgical incision from the abdominal wall, whereas VAT was obtained from the epiploon. Adipose tissue samples were immediately transported to the laboratory in ice, washed in PBS one times, frozen in liquid N 2 , and stored at Ϫ80 C.
Analytical methods
Glucose, cholesterol, and triglycerides plasma levels were determined in a Hitachi 737 autoanalyzer (Roche Molecular Biochemicals, Marburg, Germany) using the standard enzyme methods. High-density lipoprotein cholesterol was quantified after precipitation with polyethylene glycol at room temperature (PEG-6000, Merck Schuchardt OHG, Hohenbrunn, Germany). Plasma insulin, levels of soluble IL-6, and plasma free fatty acids were measured as described elsewhere (13) .
Gene expression-relative quantification of adipose tissue samples
Four hundred to 500 mg frozen adipose tissue was used for RNA extraction. RNA was reverse transcribed to cDNA and the following genes were assayed using Taqman assays (Applied Biosystems, Foster City, CA): Fn14 (Hs00171993_m1); TWEAK (Hs00611242_m1); VISFATIN (Hs00237184_m1); heat shock protein (HYOU1) (Hs00197328_m1); fastinginduced adipose factor (Hs00211522_m1); hypoxia-inducible factor (HIF)-1a (Hs00153153_m1); vascular endothelial growth factor (VEGF) (Hs00900054_m1); glucose trans- ). All data were expressed as an n-fold difference relative to a calibrator (a mix of different depot samples).
Cell culture and stimuli
SGBS preadipocyte cells were induced to differentiate to mature adipocytes as described (14) . Differentiation was checked by accumulation of intracellular lipids by Oil Red O (Sigma-Aldrich, Barcelona, Spain).
Adipocytes were cultured overnight in serum-free DMEM/ F12 (1:1) (Invitrogen, Barcelona, Spain) medium before stimuli.
The human monocytic THP-1 cell line (European Collection of Cell Culture, Wiltshire, UK) was used and cultured as described by Chacó n et al. (15) . Cells were serum deprived overnight before stimulation.
Inflammatory stimuli
Adipocytes were stimulated for 24 h with 10 and 100 ng/ml with human recombinant (hr) TWEAK (PeproTech, Barcelona, Spain) and 50 ng/ml TNF␣ (Peprotech). THP-1 cells were treated with 100 ng/ml lipopolysaccharide (LPS; Sigma-Aldrich) for 8 h.
Hypoxia and ER stress stimuli
Adipocytes were incubated at 37 C in a humidified atmosphere of 95% air-5% CO 2 or placed into a hypoxic chamber (Billups-Rothenberg, Dell Mar, CA) flushed with gas mixture consisting of 1% O 2 , 5% CO 2 , and 94% N 2 . Cells were incubated for 24 h at 37 C under these conditions. Chemical hypoxia was induced by treating cells with 200, 100, and 500 M CoCl 2 (Sigma-Aldrich) for 8 or 24 h. ER stress was induced by the addition of 1-5 g/ml of tunicamycin (Sigma-Aldrich) for 8 or 24 h. Dimethylthiazoldiphenyltetra-zoliumbromide-based in vitro toxicology assay kit and the lactate dehydrogenase-based assay kit were used as a measure of cell viability (Sigma-Aldrich) in response to hypoxia, TNF␣, IL-6, and LPS treatment, as recommended by the manufacturers. Assays were performed in triplicates. We checked that the concentrations used and the length of incubations were noncytotoxic for SGBS and THP-1 cells (data not shown).
Inhibitor experiments
The signaling pathway was studied by using inhibitors concomitant with 100 ng/ml TWEAK stimulus for 8 h: 10 M parthenolide, 10 M U0126, and 10 M SP0600125 (Merck Chemicals, Barcelona, Spain).
RNA from THP-1 and SGBS mature adipocytes were extracted as described (15) . Genes assayed were: TWEAK, Fn14, HIF-1␣, and GRP78 using the probes mentioned above and the following probes for: MCP-1 (Hs00234140_m1), IL-6 (Hs00985641_m1), LEP (leptin; Hs00174877_m1), APM1 (adiponectin; Hs00605917_m1), and TNF␣ (Hs00174128_m1).
Western blotting
The Western blotting technique was performed as already described (16) . A total of 40 g of protein were subjected to 15% SDS-PAGE, transferred to nitrocellulose membranes, and probed with anti-TWEAK goat polyclonal antibody (R&D Systems, Vitro S.L., Madrid, Spain) (1:1000) and anti-Fn14 affinity-purified antirabbit (Cell Signaling Technology, Beverly, MA). Rabbit and goat IgG conjugated with peroxidase was used as secondary antibody (1:5000). Placenta and human umbilical endothelial cell protein extracts were used as positive control. All blots were developed with SuperSignal West Femto chemiluminescent substrate (Pierce Biotechnology, Boston, MA) and visualized by VersaDoc imaging system and Quantity One software (Bio-Rad, Barcelona, Spain).
Statistical analysis
For clinical and anthropometrical variables, normal distributed data are expressed as mean value Ϯ SD, and for variables with no Gaussian distribution, values are expressed as median (75th percentile). In vitro experimental results are presented as means Ϯ SD from three independent experiments performed in duplicates. Statistical significance was tested with the unpaired Student's t test or Mann-Whitney U test for nonnormally distributed data or one-way ANOVA followed by the protected least-significant difference test or by Kruskal-Wallis U for nonnormally distributed data. P Ͻ 0.05 was considered significant.
Results
TWEAK and Fn14 are overexpressed only in adipose tissue in severe obesity
The main anthropometric and analytical characteristics of the obese, type 2 diabetes, and severely obese cohorts in our study are presented in Table 1 . When we analyzed TWEAK and Fn14 gene expression in the SAT and VAT adipose tissue depots in the above-mentioned cohorts, only severely obese patients showed that both TWEAK and Fn14 were significantly overexpressed in both SAT and VAT depots when compared with their control group (Table 2 ). In obese and type 2 diabetic study cohorts, VAT and SAT TWEAK and Fn14 expression lev- 
SAT ϭ VAT P ϭ 0.477 els did not change among obesity groups or with the presence of type 2 diabetes (Table 2) . Intragroup study of expression levels of TWEAK and Fn14 in paired SAT and VAT samples showed that in obese and severely obese subjects, TWEAK expression was similar in both depots (Table 3 ). In lean, overweight, and type 2 diabetic subjects, TWEAK expression was higher in SAT than VAT (Table 3) . Fn14 was predominantly expressed in VAT samples in lean, overweight, and severely obese subjects, whereas in obese and type 2 diabetic subjects, the expression was similar (Table 3) .
Hypoxia and ER gene expression markers are highly expressed in SAT and VAT tissue of the severely obese subjects Hypoxia could be behind the overexpression of TWEAK and Fn14 in severe obese adipose tissue, and hence, we analyzed the relative expression levels in SAT and VAT depots from our obese and severely obese cohorts of widely accepted surrogate genes for hypoxia (2) and ER stress (4) listed in Table 4 . Genes selected were: HIF-1␣, a key transcription factor in hypoxia; VEGF, an angiogenic marker hypoxia regulated; VISFATIN, a proinflammatory and potentially insulin-mimetic adipokine regulated by HIF-1␣; FIAF (fasting-induced adipose factor), involved in lipid metabolism and up-regulated by HIF-1␣; GLUT-1, a glucose transporter gene found to be increased under hypoxia; and HYOU1, an oxygen-regulated gene. The markers of ER stress transducers selected were: XBP-1; X-box, a transcription factor that modulates the ER stress response; and GRP78, a glucose-regulated gene strongly related with hypoxia (see Supplemental Table 1 , published as supplemental data on The Endocrine Society's Journals Online web site at http://jcem.endojournals.org).
We observed that in the severely obese subjects, all selected genes were significantly up-regulated when compared with the control group (Table 4) . Almost all analyzed genes (excepted FIAF, HIYOU, and GRP78) were expressed in significantly higher amounts in VAT than SAT depots.
In contrast, in the obesity study cohort, only VEGF was found to beup-regulatedinleansubjectswithoutdifferencesfor the rest of hypoxia and ER stress-explored genes (Table 4) . No significant differences in gene expression levels were found with the presence of type 2 diabetes for the selected hypoxia or endoplasmic reticulum gene markers (data not shown).
Inflammatory but not hypoxic or ER stress stimuli modulate Fn14 expression in human adipocytes
In view of the above-mentioned results, we questioned whether inflammation, hypoxia, or hypoxia-induced ER stress could be behind the up-regulation of TWEAK and ER stress GRP78 0.9 Ϯ 0.2
Differences when comparing same depot between obesity group study (P Ͻ 0.05).
b Differences when comparing depots within same obesity group (P Ͻ 0.05).
Fn14 mRNA in the severely obese subjects. To this end we analyzed TWEAK and Fn14 expression in SGBS mature adipocytes under hypoxic conditions induced either chemically (CoCl 2 ) or by low oxygen tension (1% O 2 ). In these conditions, whereas TWEAK and Fn14 gene expression was not affected (Fig. 1, A and C) , IL-6 and LEP mRNA were up-regulated (Fig. 1,  A, B, and D) . TNF␣ gene expression was below detection levels (data not shown).
We found that HIF-1␣ gene expression was down-regulated by the hypoxic stimulus and GRP78 expression was not altered (Fig. 1A) .
To analyze the effect of an ER stress stimulus on TWEAK and Fn14 expression in adipocytes, we used 1 g/ml of tunicamycin for 24 h. We observed that tunicamycin had no effect on TWEAK or Fn14 expression. However, IL-6, LEP, and GRP78 expression were altered under these conditions (Fig. 1E) .
In contrast, when we tested an inflammatory stimulus (50 ng/ml TNF␣ for 24 h), we found Fn14 expression significantly increased at mRNA (Fig.  1C ) and protein levels (Fig. 1G) .
Both stimuli together, hypoxia and inflammation, did not affect TWEAK gene expression and did not increase the inflammatory effect of TNF␣ over Fn14 gene expression (Fig. 1C) . TNF␣ significantly increased HIF-1␣ and GRP78 (Fig. 1D) .
Also, as an inflammatory stimulus, we tested IL-6 for 24 h, which produced a significant increase in Fn14 gene expression, whereas TWEAK gene expression was not altered (Fig. 1F) .
Inflammatory stimuli but not hypoxia or ER stress stimuli modulate TWEAK expression in macrophages
Macrophages are an important component of adipose tissue milieu in severe obesity and have been shown to contribute to the inflammatory state observed in obesity. To analyze the effect on TWEAK and Fn14 of a hypoxic or an inflammatory stimulus over human macrophages, we tested THP-1 human macrophage cell line under a chemical hypoxic stimulus. We found that hypoxia, induced chemically with 100 M CoCl 2 , did not change the expression levels of TWEAK and Fn14 (Fig. 2, A  and B) . We decided to use a dose of 100 ng/ml LPS as an inflammatory stimulus on phorbol-12-myristate-13-acetatepretreated THP-1 cells instead of TNF␣ because doses of TNF␣ ranging from 0.1 to 50 ng/ml for 8 h produced no significant effect on cytokine stimulation (data not shown). Both LPS and TNF␣ are known to activate in THP-1 overlapping signaling pathways (17, 18) , although with different intensities. We observed that an inflammatory stimulus induced by LPS significantly up-regulated TWEAK and HIF-1␣ gene expression and down-regulated Fn14 (Fig. 2B) .
IL-6 and TNF␣ mRNA were found both significantly up-regulated under inflammation induced by LPS, but chemical hypoxia up-regulated only IL-6 (Fig. 2C ).
An ER stress stimulus induced by 5 g/ml tunicamycin for 8 h significantly increased IL-6, TNF␣, and GRP78 but did not alter TWEAK gene expression. Fn14 mRNA was found significantly down-regulated by tunicamycin (Fig. 2D) . IL-6 stimuli over THP-1 macrophage significantly upregulated only TWEAK gene expression levels (Fig. 2E) .
TWEAK acts as proinflammatory cytokine over human adipocyte cells
To explore the role of TWEAK over adipocytes, we stimulated SGBS adipocytes with 10 or 100 ng/ml hrTWEAK for 24 h. TWEAK stimulation led to a significant increase in mRNA levels of IL-6 and MCP-1 (Fig.  3A) . Fn14, APM1, and LEP gene expression were un- changed under these conditions. TNF␣ mRNA levels were undetectable (Fig. 3A) .
To determine which signaling pathway was switched on, we used parthenolide as NF-B inhibitor, U0126 as MAPK kinase-ERK1/2 inhibitor, and SP600125 as c-Jun N-terminal kinase (JNK) inhibitor. We observed that inhibition of NF-B and MAPK kinase-ERK1/2 reduced the gene expression of IL-6 and MCP-1, whereas JNK inhibition did not reduce the expression of IL-6 and increased MCP-1 expression (Fig. 3B) .
Discussion
Within adipose tissue, a common feature of the inflammatory process associated with obesity is the altered expression of many cytokines and adipokines. We recently reported that the TWEAK/Fn14 axis may be a new component of the network that participates in the inflammatory imbalance observed in obesity and insulin resistance states (10) . In this sense, Tweak and Fn14 expression have been detected in carotid atherosclerotic plaques, suggesting a pathological role of TWEAK/Fn14 axis in this obesity-related comorbidity (19) .
In the present study, we showed that TWEAK/Fn14 up-regulation in SAT and VAT tissue was linked to severe obesity. One particularity of severe obesity is the presence of elevated systemic inflammation (11, 12) . At tissue level, the precise mechanisms behind this inflammatory response as the adipose tissue mass expands are not well known. It has been suggested that hypoxia could be a key trigger of adipose tissue dysfunction because hypoxia generates tissue inflammation (2) . In obese human subjects, decreased oxygen partial pressure within the adipose tissue was paralleled by an increase in the expression and secretion of the chemokine and markers of macrophage infiltration (20) .
Interestingly, we found up-regulation of hypoxia response genes such as VEGF, GLUT1, FIAF, VISFATIN, and HIF-1␣ only in our cohort of severely obese patients. The up-regulation of HIF-1␣ observed in adipose tissue of our severely obese subjects is in accordance with previous reports (21) . However, in view of our own and others' in vitro studies that showed HIF-1␣ mRNA down-regulation in adipocytes (2), the high expression found in whole adipose tissue may be accounted for mainly by the cells in the stromovascular fraction, as has been previously suggested (22) . No changes in hypoxia and ER stress genes were observed in our obese cohort; only VEGF was found overexpressed in the lean subjects, which is in accordance with a recent scientific report (20) .
On the other hand, the proinflammatory milieu facilitated by hypoxia in adipose tissue may represent an important stimulus for macrophage attraction. It is known that adipose tissue in severe obesity is highly infiltrated (up to 40%) with macrophages; this in turn generates a vicious circle producing a high degree of tissue inflammation (22) .
In view of the parallel up-regulation of TWEAK/Fn14 (this study and Ref. 10) and hypoxia-specific genes in severe obesity, we considered that hypoxia could be modulating TWEAK/Fn14 gene expression in adipose tissue of these patients. Our experimental data showed that hypoxia did not regulate per se TWEAK and Fn14 expression in SGBS adipocytes cells or THP-1 macrophage. Similarly to hypoxia, TWEAK and Fn14 expression in both adipocytes and macrophage cells was not changed by an ER stress stimulus, whereas changes in the production of inflammation-related cytokines in SGBS adipocyte cells were consistent with the original hypoxia hypothesis; IL-6 and LEP were found up-regulated and TNF␣ was not altered under hypoxic conditions (23, 24) .
Inflammatory stimuli in vitro differentially increased the expression of TWEAK in macrophages and Fn14 in adipocytes. But both hypoxia and inflammatory stimulus strongly increased expression, in both adipocytes and macrophages, of IL-6, a potent inflammatory cytokine. On the other hand, IL-6 circulating levels were highly increased in our severely obese subjects. Moreover, hypoxia has been described as a positive stimulus for IL-6 (25) . Interestingly, when we stimulated adipocyte and macrophage cells with IL-6, we observed the same effects as depicted by the inflammatory stimuli of TNF␣ in adipocytes and LPS in macrophages: a specific up-regulation of TWEAK in macrophages and Fn14 in adipocytes. These finding suggest a possible paracrine action of TWEAK expressed by macrophages over Fn14 up-regulated receptor in adipocytes.
In adipose tissue fractions of severely obese subjects, expression of Fn14 was higher in the stromovascular fraction than in the mature isolated adipocyte (10) . However, the precise contribution of adipocytes, macrophages and other cells to the production of TWEAK and Fn14 is difficult to assess quantitatively. It is not certain whether the process of preparation and subsequent incubation of the different cell fractions alters their relative rate of production and release of various adipokines. In addition, large adipocytes show the highest rates of production of inflammatory adipokines (26) , but because of their greater fragility, they are likely to be underrepresented, or absent, from most cell fractionations.
What, in turn, could be the biological effect of TWEAK over adipocytes? Our experiments suggest an active participation of TWEAK in the inflammatory environment found in obesity because we show for the first time that TWEAK has a proinflammatory effect over human adipocyte cells in which it induces the expression of the proinflammatory cytokines IL-6 and MCP-1. What could the molecular mechanisms be by which adipocytes sense and respond to TWEAK? In other cell types, the binding of TWEAK to its receptor, Fn14, has been shown to activate a limited set of signaling pathways involved in cell proliferation and differentiation, including NF-B activation, which is associated with its proinflammatory effect (6): MAPK, JNK, ERK (27) , and p38 MAPK (28, 29) . Here we showed that activation of NF-B and ERK1/2 signaling pathways was implicated in the proinflammatory process of TWEAK over human adipocytes. In THP-1 macrophage cells, TWEAK signal transduction has been shown to be NF-B dependent and induced the degradation of inhibitory-B (30).
In conclusion, in the present paper, we show, for the first time, that TWEAK acts as a proinflammatory cytokine in human adipocyte cells. We report an overexpression of TWEAK/Fn14 and hypoxia characteristic genes in both SAT and VAT adipose tissue depots of severely obese patients; however, both TWEAK and Fn14 genes were not hypoxia sensitive. The increment of TWEAK and Fn14 in severe obesity may be due to the inflammatory environment, in particular that caused by the presence of IL-6, a cytokine that could be playing a key role in TWEAK/Fn14 regulation.
